3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Infectious Mononucleosis
1
Epstein-Barr Virus Infections
1
Interventions
Rituximab
5
Valganciclovir
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
valomaciclovir
1
threonic acid
1
pembrolizumab
1
otelixizumab
1
merphos
1
cc-486
1
avelumab
1
Zidovudine
1
Vincristine
1
Valacyclovir
1
Tomography, X-Ray Computed
1
Prednisone
1
Magnesium Sulfate
1
Interferons
1
Hydroxyurea
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Cyclophosphamide
1
Caves
1
Carboplatin
1
Brentuximab Vedotin
1
Bortezomib
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Epstein-Barr Virus Infections
×
valomaciclovir
×
Clear all
NCT00575185
2017-03-22
Mono6
University of Minnesota
Phase 1/2
Completed
23 enrolled
8 charts